Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 64 results found. Search for [ Habil Khorakiwala ]

Results 1 to 21 of 64
BusinessToday.In
August 4, 2020
Market cap of Wockhardt rose to Rs 3,695.50 crore as of today's session. The stock price of Wockhardt has gained 21% in one month and 42% since the beginning of the year


E Kumar Sharma
February 13, 2020
The deal will enable adequate liquidity for robust growth in international operations and investments in Biosimilars for the US market; augment the remaining domestic branded business portfolio of the company and re-focus towards chronic segment with differentiated product portfolio, according to Wockhardt


E Kumar Sharma
January 17, 2020
The Indian Pharmaceutical Alliance in its statement released on 15 January said: There was no discussion at all on the alleged bribes being given by pharma companies to doctors as being reported in the media


PB Jayakumar
January 16, 2020
Wockhardt latest medicines: Wockhardt announces two new drugs for skin infections, its shares rise by 14 per cent intraday. Here's what this means


BusinessToday.In
January 16, 2020
Wockhardt said the two approved new antibiotics, Emrok(IV) & Emrok O are used for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia.


PTI
October 17, 2019



PTI
July 8, 2019



PTI
April 10, 2019



PTI
March 1, 2019



PTI
March 1, 2019



PTI
January 21, 2019



PB Jayakumar
New Delhi, April 27, 2018
Though mired in promoter issues and complex management holding structures in the past, there are many factors that make Fortis a 'must chase' target for leading domestic and international chains, say experts in the healthcare industry.


P.B. Jayakumar
Delhi, May 1, 2017
Unlike many of the India Inc. successors who had got smoothly running companies on a platter, Habil Khorakiwala's younger son Murtaza faced a tough beginning.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


BT Online
New York, March 21, 2017
India is home to world's fourth highest number of billionaires with Reliance Industries chief Mukesh Ambani leading the club of more than 100 super rich Indians, according to a new list released by Forbes magazine.


By Joe C. Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


PTI
September 25, 2016
From Ambanis and Adanis to Premjis and Khorakiwalas, several generation-next leaders of India's leading family-run businesses have joined crorepati club when it comes to their salaries and other perks.


PB Jayakumar
January 21, 2016
The 'Declaration on Combating Antimicrobial Resistance' signed at the World Economic Forum in Davos, Switzerland, sets out for the first time how governments and industry need to work together.


BT Online
New Delhi, December 8, 2015
The stock gained after USFDA granted breakthrough qualified infectious disease product (QIDP) drug discovery status to the new antibiotic product of the company.


PTI
New Delhi, June 22, 2015
Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.


PAGES 1 OF 4  1234